Sharoky Melvin MD's Form 4 filing
INSMED Inc (INSM) · filed Aug 19, 2026
- Accession no.
- 0001182633-26-000010
- Filed
- Aug 19, 2026, 4:10 PM ET
- Trade date
- Aug 17, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $637.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sharoky Melvin MDCIK 0001182633 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | SSaleDisposed | −5,000 | $127.53F1 | −$637,650 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This is the weighted average sales price representing 5,000 shares sold at prices ranging from $127.51 to $127.61 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.